Annual CFF
$70.50 M
-$56.47 M-44.48%
31 December 2023
Summary:
AlloVir annual cash flow from financing activities is currently $70.50 million, with the most recent change of -$56.47 million (-44.48%) on 31 December 2023. During the last 3 years, it has fallen by -$221.48 million (-75.86%). ALVR annual CFF is now -75.86% below its all-time high of $291.98 million, reached on 31 December 2020.ALVR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
-$21.00 K-100.00%
30 September 2024
Summary:
AlloVir quarterly cash flow from financing activities is currently $0.00, with the most recent change of -$21.00 thousand (-100.00%) on 30 September 2024. Over the past year, it has stayed the same.ALVR quarterly CFF is now -100.00% below its all-time high of $292.33 million, reached on 30 September 2020.ALVR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$32.00 K
$0.000.00%
30 September 2024
Summary:
AlloVir TTM cash flow from financing activities is currently $32.00 thousand, unchanged on 30 September 2024. Over the past year, it has dropped by -$70.74 million (-99.95%). ALVR TTM CFF is now -99.99% below its all-time high of $292.33 million, reached on 30 September 2020.ALVR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALVR Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.5% | 0.0% | -100.0% |
| 3 y3 years | -75.9% | -100.0% | +117.1% |
| 5 y5 years | +208.2% | 0.0% | -100.0% |
ALVR Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -75.9% | >+9999.0% | -100.0% | -100.0% | +117.1% | |
| 5 y | 5 years | -75.9% | >+9999.0% | -100.0% | +100.0% | -100.0% | +117.1% |
| alltime | all time | -75.9% | >+9999.0% | -100.0% | +100.0% | -100.0% | +117.1% |
AlloVir Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | $32.00 K(0.0%) |
| June 2024 | - | $21.00 K(+90.9%) | $32.00 K(-100.0%) |
| Dec 2023 | $70.50 M(-44.5%) | $11.00 K(>+9900.0%) | $70.50 M(-0.4%) |
| Sept 2023 | - | $0.00(-100.0%) | $70.78 M(-64.1%) |
| June 2023 | - | $70.48 M(>+9900.0%) | $197.20 M(+55.3%) |
| Dec 2022 | $126.96 M(>+9900.0%) | $292.00 K(-99.8%) | $126.96 M(+0.2%) |
| Sept 2022 | - | $126.42 M(>+9900.0%) | $126.73 M(>+9900.0%) |
| June 2022 | - | $244.00 K(+275.4%) | $476.00 K(+105.2%) |
| Dec 2021 | $232.00 K | $65.00 K(-61.1%) | $232.00 K(-224.1%) |
| Sept 2021 | - | $167.00 K(>+9900.0%) | -$187.00 K(-100.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $0.00(0.0%) | $291.98 M(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) | $291.98 M(0.0%) |
| Dec 2020 | $291.98 M(+141.5%) | -$354.00 K(-100.1%) | $291.98 M(-0.1%) |
| Sept 2020 | - | $292.33 M(>+9900.0%) | $292.33 M(>+9900.0%) |
| June 2020 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2020 | - | $0.00(0.0%) | $120.95 M(+0.0%) |
| Dec 2019 | $120.92 M(+428.7%) | $0.00(0.0%) | $120.92 M(0.0%) |
| Sept 2019 | - | $0.00(-100.0%) | $120.92 M(0.0%) |
| June 2019 | - | $120.95 M(<-9900.0%) | $120.92 M(<-9900.0%) |
| Mar 2019 | - | -$31.00 K | -$31.00 K |
| Dec 2018 | $22.87 M | - | - |
FAQ
- What is AlloVir annual cash flow from financing activities?
- What is the all time high annual CFF for AlloVir?
- What is AlloVir annual CFF year-on-year change?
- What is AlloVir quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AlloVir?
- What is AlloVir quarterly CFF year-on-year change?
- What is AlloVir TTM cash flow from financing activities?
- What is the all time high TTM CFF for AlloVir?
- What is AlloVir TTM CFF year-on-year change?
What is AlloVir annual cash flow from financing activities?
The current annual CFF of ALVR is $70.50 M
What is the all time high annual CFF for AlloVir?
AlloVir all-time high annual cash flow from financing activities is $291.98 M
What is AlloVir annual CFF year-on-year change?
Over the past year, ALVR annual cash flow from financing activities has changed by -$56.47 M (-44.48%)
What is AlloVir quarterly cash flow from financing activities?
The current quarterly CFF of ALVR is $0.00
What is the all time high quarterly CFF for AlloVir?
AlloVir all-time high quarterly cash flow from financing activities is $292.33 M
What is AlloVir quarterly CFF year-on-year change?
Over the past year, ALVR quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is AlloVir TTM cash flow from financing activities?
The current TTM CFF of ALVR is $32.00 K
What is the all time high TTM CFF for AlloVir?
AlloVir all-time high TTM cash flow from financing activities is $292.33 M
What is AlloVir TTM CFF year-on-year change?
Over the past year, ALVR TTM cash flow from financing activities has changed by -$70.74 M (-99.95%)